Table of contents


In this issue

p635 | doi:10.1038/nrc901

Top

Research Highlights

Genomic instability: Chromosome crisis

p638 | doi:10.1038/nrc888

Tumorigenesis: Hang on tight!

p638 | doi:10.1038/nrc890

Tumour progression: Destroy the environment!

p638 | doi:10.1038/nrc891

Immunology: Presentation is everything

p638 | doi:10.1038/nrc893

In the news

Collaborative effort

p638 | doi:10.1038/nrc896

News in Brief

Glioblastoma | Cell Migration | Epidemiology | Therapeutics

p639 | doi:10.1038/nrc895

Therapeutics: Stop signals

p640 | doi:10.1038/nrc892

Genetics: Bridging the divide

p641 | doi:10.1038/nrc897

Trial Watch

Targeting leukaemia | Efficacy of imatinib

p641 | doi:10.1038/nrc898

Oncogenes: One small step for mankind...

p642 | doi:10.1038/nrc889

Tumour immunity: Plugging the gap

p642 | doi:10.1038/nrc902

Angiogenesis: Endostatin and Wnt signalling

p643 | doi:10.1038/nrc894

Top

News and Analysis

From the analyst's couch

Selective anticancer drugs

p645 | doi:10.1038/nrc900

Top

Reviews

The Bcl2 family: regulators of the cellular life-or-death switch

Suzanne Cory & Jerry M. Adams

p647 | doi:10.1038/nrc883

Strategies for MMP inhibition in cancer: innovations for the post-trial era

Christopher Mark Overall & Carlos López-Otín

p657 | doi:10.1038/nrc884

Molecular basis of the VHL hereditary cancer syndrome

William G. Kaelin, Jr

p673 | doi:10.1038/nrc885

Molecular imaging of cancer with positron emission tomography

Sanjiv Sam Gambhir

p683 | doi:10.1038/nrc882

Are vitamin and mineral deficiencies a major cancer risk?

Bruce N. Ames & Patricia Wakimoto

p694 | doi:10.1038/nrc886

Top

Perspective

Timeline

How acute promyelocytic leukaemia revived arsenic

Jun Zhu, Zhu Chen, Valérie Lallemand-Breitenbach & Hugues de Thé

p705 | doi:10.1038/nrc887

Natureview: Reviews and comment from the nature publishing group

p715 | doi:10.1038/nrc899

Extra navigation

Subscribe

Subscribe to Nature Reviews Cancer

naturejobs

natureproducts


Advertisement